02 febbraio 2018 Radioterapia

Mitchell Cancer Institute, US, selects RayStation for TomoTherapy

The University of South Alabama Mitchell Cancer Institute (MCI) in Mobile, Alabama, has selected RayStation* as its treatment planning system for the TomoTherapy ® System. The center also treats patients using a CyberKnife ®System and will use RayStation* for this in the future.

MCI’s radiation therapy service is equipped with state-of-the-art Accuray´s CyberKnife and TomoTherapy System, as well as a 64-slice PET-CT scanner. The center was initially interested in RayStation’s forthcoming support for the CyberKnife System, but quickly saw that the system could meet all of its treatment planning needs into the future, including the TomoTherapy System.

Dr. Weisi Yan, Director of the CyberKnife Program at MCI, says: “We were very impressed by the capabilities and user-friendliness of RayStation. As a leading-edge treatment center, we need the best possible technology in order to deliver outstanding care and maximize efficiency. RayStation will help us to achieve our goals.”

Hal Hopper, Manager of MCI’s Department of Radiation Oncology, says: “RayStation is fast and effective in planning treatments for all possible techniques we are likely to offer. It is much less labor-intensive than other systems we have used. With RayStation, the physician can choose the best course of treatment more quickly.”

Johan Löf, CEO of RaySearch, says: “MCI shares our vision of continuously advancing cancer treatment. We are very pleased to be able to meet their requirements for advanced clinical techniques as well as optimized workflows and use of resources.”
    

 

About MCI
Founded in 2000, MCI provides cancer treatment in three locations: MCI headquarters in Mobile, the MCI Kilborn Clinic in Fairhope and Monroe County Hospital in Monroeville. The center’s researchers and clinicians focus daily on the battle against cancer serving a potential catchment population of more 4.1 million people, with a singular focus of advancing cancer diagnosis, treatment and prevention in the region and beyond. Since its establishment, the center’s strategic goal has remained constant: to achieve competitiveness for future designation as an NCI Comprehensive Cancer Center and to achieve self-sustaining, long-term financial viability.

News

22/05/2018 News

Piattaforma per l’analisi e la comparazione delle immagini di tomosintesi della mammella”: il 28 maggio al CRO l’evento finale di progetto

Si terrà lunedì 28 maggio al CRO – Centro di Riferimento Oncologico di Aviano l’evento di presentazione finale del progetto “Piattaforma per l’analisi e la comparazione delle immag [...]

21/05/2018 News

Strong uptake of RayStation Monte Carlo dose engine among proton therapy centers

13 out of 18 RayStation proton sites in clinical operation are now using the proton Monte Carlo (MC) dose engine, and this just a year after it was released. That according to a survey. “The implementation of th [...]

08/05/2018 Radioterapia

AL VIA IL NUOVO PROTON CENTER ALLO IEO DI MILANO

Tecnologie Avanzate è lieta di annunciare che giovedì 3 maggio è stato firmato l'accordo tra lo IEO - Istituto Europeo di Oncologia di Milano e la IBA (Ion Beam Applications, S.A, Euronext) per [...]

Eventi

20gen2017 | Eventi

RayCare Symposium, Roma 26 gennaio 2017

Tecnologie Avanzate è lieta di comunicare che il 26 gennaio organizza a Roma il primo RayCare Symposium, un incontro destinato a presentare in [...]

24mag2018 | Medicina nucleare

Corso Nazionale AIMN, Bergamo, 24-26 maggio 2018

Tecnologie Avanzate sarà sponsor del Corso Nazionale AIMN che avrà luogo a Bergamo il 24-26 maggio 2018.

Video gallery